A specialized Sickle Cell service at the Royal London Hospital is scheduled to cease operations after a temporary six-month trial, causing concern among patients who depend on the service for pain crises. The service, which provides prompt access to specialized care for individuals with sickle cell disease, a group of inherited conditions affecting red blood cells prevalent in individuals of African or Caribbean descent, is set to close on January 30. Patients are anxious about the closure potentially forcing them to seek care at general A&E departments.
A petition initiated by London sickle cell patient Delo Biye, 48, has garnered twenty-four thousand signatures in opposition to the closure, citing fears that lives could be endangered. The Royal London unit’s closure is part of a broader trend of specialist services being at risk, with only seven similar emergency specialist sickle cell services nationwide. NHS England has been evaluating a two-year pilot of emergency department bypass units, coinciding with the closure of the Royal London service.
Delo, a frequent user of the unit for urgent care needs, highlights the significant difference in receiving specialized support from dedicated staff at the unit compared to generic NHS teams less familiar with the condition. The closure of such specialized services raises concerns among patients and families about the diminishing availability of tailored care despite the increasing demand and longstanding disparities in healthcare.
The Sickle Cell Society has endorsed Delo’s petition, emphasizing the historical inadequacies in emergency care for individuals with sickle cell disease. The charity advocates for sustained funding for specialized sickle cell services and emphasizes the importance of data-driven evaluation in healthcare service decisions to ensure optimal patient outcomes and support for healthcare professionals.
John James, CEO of the Sickle Cell Society, stresses the repercussions of failed emergency care on individuals with sickle cell disease, noting the common fear among patients of not being believed or receiving inadequate treatment leading to life-threatening risks. The loss of the specialized unit is viewed by patients as part of a broader pattern of diminishing specialist sickle cell services, prompting continued advocacy efforts to prevent adverse consequences resulting from the closure.